ror,sponsor_name,sponsor_article,number_of_trials,number_of_trials_10_years,indicator_10_years,number_of_trials_10_years_drug,indicator_10_years_drug,number_of_trials_10_years_within_12_months,indicator_10_years_within_12_months,number_of_trials_10_years_within_12_months_drug,indicator_10_years_within_12_months_drug,number_of_trials_10_years_france,indicator_10_years_france,number_of_trials_10_years_drug_france,indicator_10_years_drug_france,number_of_trials_10_years_within_12_months_france,indicator_10_years_within_12_months_france,number_of_trials_10_years_within_12_months_drug_france,indicator_10_years_within_12_months_drug_france
02vjkv261,Institut national de la santé et de la recherche médicale,de l',93,63,27 %,13,31 %,63,14 %,13,31 %,9703,51 %,3667,76 %,9703,32 %,3667,53 %
